LeonaBio, Inc. Other Income and Expense
LeonaBio, Inc. (LONA) reported Other Income and Expense of $985.00 thousand for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Income Statement › Other Income
us-gaap:NonoperatingIncomeExpense · last filed 2022-11-10
- LeonaBio, Inc. nonoperating income (expense) for the quarter ending 2022-09-30 was $985.00K, a 1249.32% increase year-over-year.
- LeonaBio, Inc. nonoperating income (expense) for the quarter ending 2022-06-30 was $493.00K, a 566.22% increase year-over-year.
- LeonaBio, Inc. nonoperating income (expense) for the quarter ending 2022-03-31 was $173.00K, a 105.95% increase year-over-year.
- LeonaBio, Inc. nonoperating income (expense) for the quarter ending 2021-12-31 was $103.00K, a 32.05% increase year-over-year.
- LeonaBio, Inc. nonoperating income (expense) for fiscal 2021 was $334.00K.
- LeonaBio, Inc. nonoperating income (expense) for fiscal 2020 was -$1.28M.
- LeonaBio, Inc. nonoperating income (expense) for fiscal 2019 was -$466.00K.
| Period end | Nonoperating Income (Expense) 3 month | Nonoperating Income (Expense) 6 month | Nonoperating Income (Expense) 9 month | Nonoperating Income (Expense) 9 month as first filed | Nonoperating Income (Expense) 12 month |
|---|---|---|---|---|---|
| 2022-09-30 | $985.00K 10-Q · filed 2022-11-10 | $1.48M derived: sum of 2 quarters · filed 2022-11-10 | $1.65M 10-Q · filed 2022-11-10 | $1.75M derived: sum of 4 quarters · filed 2022-11-10 | |
| 2022-06-30 | $493.00K 10-Q · filed 2022-08-15 | $666.00K 10-Q · filed 2022-08-15 | $769.00K derived: sum of 3 quarters · filed 2022-08-15 | $842.00K derived: sum of 4 quarters · filed 2022-11-10 | |
| 2022-03-31 | $173.00K 10-Q · filed 2022-05-12 | $276.00K derived: sum of 2 quarters · filed 2022-05-12 | $349.00K derived: sum of 3 quarters · filed 2022-11-10 | $423.00K derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-12-31 | $103.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $176.00K derived: sum of 2 quarters · filed 2022-11-10 | $250.00K derived: sum of 3 quarters · filed 2022-11-10 | $334.00K 10-K · filed 2022-03-28 | |
| 2021-09-30 | $73.00K 10-Q · filed 2022-11-10 | $147.00K derived: sum of 2 quarters · filed 2022-11-10 | $231.00K 10-Q · filed 2022-11-10 | $309.00K derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | $74.00K 10-Q · filed 2022-08-15 | $158.00K 10-Q · filed 2022-08-15 | $236.00K derived: sum of 3 quarters · filed 2022-08-15 | -$823.00K derived: sum of 4 quarters · filed 2022-08-15 | |
| 2021-03-31 | $84.00K 10-Q · filed 2022-05-12 | $162.00K derived: sum of 2 quarters · filed 2022-05-12 | -$897.00K derived: sum of 3 quarters · filed 2022-05-12 | -$637.00K derived: sum of 4 quarters · filed 2022-05-12 | |
| 2020-12-31 | $78.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | -$981.00K derived: sum of 2 quarters · filed 2022-03-28 | -$721.00K derived: sum of 3 quarters · filed 2022-03-28 | -$1.28M 10-K · filed 2022-03-28 | |
| 2020-09-30 | -$1.06M 10-Q · filed 2021-11-10 | -$799.00K derived: sum of 2 quarters · filed 2021-11-10 | -$1.36M 10-Q · filed 2021-11-10 | -$1.34M 10-Q · filed 2020-11-12 | -$1.97M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $260.00K 10-Q · filed 2021-08-16 | -$300.00K 10-Q · filed 2021-08-16 | -$911.00K derived: sum of 3 quarters · filed 2021-08-16 | -$906.00K derived: sum of 4 quarters · filed 2021-08-16 | |
| 2020-03-31 | -$560.00K 10-Q · filed 2021-05-13 | -$1.17M derived: sum of 2 quarters · filed 2021-05-13 | -$1.17M derived: sum of 3 quarters · filed 2021-05-13 | ||
| 2019-12-31 | -$611.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | -$606.00K derived: sum of 2 quarters · filed 2021-03-25 | -$466.00K 10-K · filed 2021-03-25 | ||
| 2019-09-30 | $5.00K 10-Q · filed 2020-11-12 | $145.00K 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |